SCHEMBL7220223

SCHEMBL7220223

Fc1ccc([CH]Cc2ccc3ccccc3c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.48
CYP2A6 P11509 2/20 0.48
RAB9A P51151 1/20 0.46
RELA Q04206 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39
FAAH O00519 1/20 0.39
NFE2L2 Q16236 1/20 0.38
ALOX5 P09917 1/20 0.38
MCHR1 Q99705 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8710672 0.85 CYP1A2 (0.50) CYP1A2CYP2A6RAB9ARELAMAOA
SCHEMBL8668861 0.85 RAB9A (0.51) CYP1A2CYP2A6RAB9ARELAHTR2A
SCHEMBL7764479 0.83 RAB9A (0.46) CYP1A2CYP2A6RAB9ARELAMAOA
SCHEMBL7210308 0.80 CYP2A6 (0.52) CYP1A2CYP2A6RAB9AALDH1A1L3MBTL1
SCHEMBL8364378 0.79 TRPA1 (0.45) RAB9AMAOAMAOBNFE2L2
SCHEMBL654153 0.77 NFE2L2 (0.52) MAOBNFE2L2KDM4EALDH1A1L3MBTL1
SCHEMBL8210813 0.77 NFE2L2 (0.52) CYP2A6MAOAMAOBNFE2L2KDM4E
SCHEMBL5941183 0.77 NFE2L2 (0.50) CYP1A2RAB9AMAOAMAOBNFE2L2
SCHEMBL9423244 0.76 MAOA (0.51) CYP1A2RAB9AMAOAMAOBKDM4E
SCHEMBL28746131 0.76 CYP1A2 (0.58) CYP1A2CYP2A6HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6503898-B1 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-01-07 US disclosed
US-RE37781-E1 VIRICIDES, PROTEASE INHIBITOR DUPONT PHARMACEUTICALS COMPANY 2002-07-02 US disclosed
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed